Flex Pharma, a biotechnology company, has appointed Jeffrey Capello to its board of directors. He also will serve as chair of the audit committee.
Appointed in 2014, Capello is chief financial officer Ortho-Clinical Diagnostics, which was acquired by The Carlyle Group from Johnson & Johnson. Prior to his role at Ortho-Clinical Diagnostics, Capello served as CFO of Boston Scientific from 2010 to 2013.
Also on Flex Pharma's board of directors are Rod MacKinnon, Nobel Laureate and scientific co-founder; John Sculley, former Apple CEO and PepsiCo President; Peter Barton Hutt, former general counsel of the Food and Drug Administration; Marc Kozin, senior advisor to L.E.K. Consulting; Stuart Randle, former CEO of GI Dynamics; and Flex Pharma Chairman and CEO Christoph Westphal.